ZSAlign Cervical Interbody System
ZSFab, Inc. · Decision date Oct 2, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 02 October 2026 for the ZSAlign Cervical Interbody System, submitted by ZSFab, Inc. of Waltham, Massachusetts, under 510(k) number K263113. The device falls under product code OVE, Intervertebral Fusion Device With Integrated Fixation, Cervical, regulation 888.3080, with the Orthopedic medical specialty and Orthopedic review panel. The application was received 09 September 2026 and was not reviewed by a third party.
A substantially equivalent finding in the 510(k) pathway is a clearance to market, not a premarket approval. The public record identifies the device and its classification but does not describe the specific components, materials, sizes or design changes submitted, nor the predicate device relied upon. The record also does not state indications for use, clinical or bench performance data, or any conditions of clearance; those details would reside in the underlying FDA review documents, which are not included here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263113
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ZSFab, Inc.
- Product code
- OVE
- Decision code
- SESE
- Decision date
- Oct 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Intervertebral Fusion Device With Integrated Fixation, Cervical.
- Applicant
- ZSFab, Inc.
- Product code
- OVE
- FDA device class
- 2
FDA decision timeline
K263113 received
Application receipt date recorded by FDA.
K263113 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OVE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NeckTune SA Cervical CageK262726 | Medyssey Co., Ltd. | 510(k) clearance | Sep 29, 2026 | FDA |
SABER-C SystemK263049 | Elevation Spine | 510(k) clearance | Sep 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ZSFab, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Waltham, MA
Sources and methodology
- Original FDA record: K263113
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
